US EditionClorox Reports Q3 Fiscal Year 2025 Results, Updates Outlook
- The Clorox Company reported its third-quarter fiscal 2025 results on May 5, 2025, with net sales reaching $1.67 billion, down 8%, primarily due to divestitures of its VMS and Argentina businesses.
- This sales decline followed heightened macroeconomic uncertainties that changed shopping behaviors, causing temporary category slowdowns and lower sales, which the company expects to continue into the fourth quarter.
- Despite the challenging, volatile environment, Clorox maintained market shares, expanded gross margins for the tenth consecutive quarter to 44.6%, and introduced new product innovations while advancing its IGNITE strategy.
- Diluted EPS rose 466% to $1.50 from a loss of $0.41 last year, though adjusted EPS fell 15% to $1.45 due to lower sales, and year-to-date cash from operations increased 94% to $687 million.
- Clorox updated its fiscal 2025 outlook to expect flat or slightly down net sales and EPS between $5.73 and $6.13, reflecting ongoing macroeconomic risks and transformational investments including a $560 to $580 million ERP system update.
20 Articles
20 Articles
Montana Standard
Clorox Reports Q3 Fiscal Year 2025 Results, Updates Outlook
Delivers lower-than-expected sales amid a challenging and volatile consumer and geopolitical environment while maintaining overall market shares and delivering its 10th consecutive quarter of gross margin expansion
Clorox’s Q3 Results Highlight Challenges in the Consumer Staple Sector
Clorox (CLX, Financial) reported disappointing Q3 2025 results, mirroring challenges faced by peers Procter & Gamble (PG, Financial) and Kimberly-Clark (KMB, Financial). The company missed both EPS and revenue expectations due to inflation impacting consumer spending. Although CLX reaffirmed its FY25 EPS guidance, it lowered its organic sales growth outlook, citing increased price sensitivity and slower volume recovery in key categories. Adjust…
Clorox (NYSE:CLX) Updates FY 2025 Earnings Guidance
Clorox (NYSE:CLX – Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 6.950-7.350 for the period, compared to the consensus EPS estimate of 7.140. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.1 billion. Clorox Stock Down 2.9 % […]
Coverage Details
Bias Distribution
- 80% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
